Your browser doesn't support javascript.
loading
Yale Cancer Center Precision Medicine Tumor Board: two patients, one targeted therapy, different outcomes.
Cecchini, Michael; Walther, Zenta; Sklar, Jeffrey L; Bindra, Ranjit S; Petrylak, Daniel P; Eder, Joseph P; Goldberg, Sarah B.
Afiliação
  • Cecchini M; Department of Medicine, Medical Oncology, Yale School of Medicine, New Haven, CT, USA.
  • Walther Z; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Sklar JL; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Bindra RS; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA.
  • Petrylak DP; Department of Medicine, Medical Oncology, Yale School of Medicine, New Haven, CT, USA.
  • Eder JP; Department of Medicine, Medical Oncology, Yale School of Medicine, New Haven, CT, USA.
  • Goldberg SB; Department of Medicine, Medical Oncology, Yale School of Medicine, New Haven, CT, USA. Electronic address: sarah.goldberg@yale.edu.
Lancet Oncol ; 19(1): 23-24, 2018 01.
Article em En | MEDLINE | ID: mdl-29304353
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ftalazinas / Piperazinas / Neoplasias da Próstata / Sarcoma / Terapia de Alvo Molecular / Inibidores de Poli(ADP-Ribose) Polimerases Tipo de estudo: Prognostic_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ftalazinas / Piperazinas / Neoplasias da Próstata / Sarcoma / Terapia de Alvo Molecular / Inibidores de Poli(ADP-Ribose) Polimerases Tipo de estudo: Prognostic_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article